4.6 Article

Heat-stimuli-enhanced osteogenesis using clinically available biomaterials

期刊

PLOS ONE
卷 12, 期 7, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0181404

关键词

-

资金

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan [26670659]
  2. Nagoya University Hospital
  3. Grants-in-Aid for Scientific Research [26670659] Funding Source: KAKEN

向作者/读者索取更多资源

A recent study reported that heat stress stimulates osteogenesis in an in vivo rat model using alginate gel and magnetite cationic liposomes. However, for clinical use, the efficacy for promoting osteogenesis needs to be investigated using clinically approved materials, and preferably with animals larger than rats. The aim of this study was to evaluate multiple heat stimuli-triggered osteogenesis in rat tibial defect models using already clinically applicable materials (Resovist (R) and REGENOS (R)) and determine the efficacy also in the rabbit. Fifty-eight rats and 10 rabbits were divided into two groups, respectively, with or without hyperthermia treatment at 45 degrees C for 15 min. (hyperthermia; 20 rats once a week, 8 rats three times a week, 5 rabbits once a week, control; 30 rats and 5 rabbits). Micro-CT assessment at 4 weeks revealed that a significantly stimulated osteogenesis was observed in the once a week group of both rats and rabbits as compared to the control group (p = 0.018 and 0.036, respectively). In contrast, the three times a week group did not show enhanced osteogenesis. Histological examination and image analysis showed consistent results in which the area of mineralized bone formation in the once a week hyperthermia group was significantly increased compared with that in the control group at four weeks (rat; p = 0.026, rabbit; p = 0.031). Newly formed bone was observed in the grafted materials from the periphery toward the center, and more osteoclasts were found in the once a week group. Heat stress also induced enhanced alkaline phosphatase expression in cultured osteoblastic cells, MC3T3, in vitro (p = 0.03). On the other hand, heat stress had no obvious effects on chondrogenic differentiation using ATDC5 cells. Our study demonstrates that heat-stimuli with clinically applicable novel heating materials can promote significant osteogenesis, and may thus be a promising treatment option for diseases associated with bone defects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Effect of Neoadjuvant Therapies on Soft Tissue Sarcomas with Tail-like Lesions: A Multicenter Retrospective Study

Hisaki Aiba, Kunihiro Ikuta, Kunihiro Asanuma, Katsuhisa Kawanami, Satoshi Tsukushi, Akihiko Matsumine, Daisuke Ishimura, Akihito Nagano, Yoji Shido, Eiji Kozawa, Kenji Yamada, Junji Wasa, Hiroaki Kimura, Takao Sakai, Hideki Murakami, Tomohisa Sakai, Tomoki Nakamura, Yoshihiro Nishida

Summary: This study investigated the effect of neoadjuvant therapy on highly malignant soft tissue tumors with tail-like lesions. The regression of lesions was related to the necrosis rate of the main part of the tumor but did not directly impact achieving surgery with a negative margin or improvements in oncological outcomes. A more comprehensive evaluation is necessary to elaborate on surgical strategy.

CANCERS (2021)

Article Oncology

Clinical Outcome in Soft Tissue Sarcoma Patients with Lung Metastasis Who Received Metastasectomy and/or Radiofrequency Ablation: Tokai Musculoskeletal Oncology Consortium Study

Tomoki Nakamura, Kunihiro Asanuma, Motoshi Takao, Takashi Yamanaka, Hiroshi Koike, Toyofumi F. Chen-Yoshikawa, Satoshi Tsukushi, Hiroaki Kuroda, Eiji Kozawa, Masaaki Sano, Hisaki Aiba, Ryoichi Nakanishi, Akihito Nagano, Kenji Yamada, Yoji Shido, Katsuhisa Kawanami, Yuya Izubuchi, Akihiro Sudo, Yoshihiro Nishida

Summary: The study investigated the oncological outcomes of lung metastasectomy and/or radiofrequency ablation in patients with soft tissue sarcoma. Results showed that complete treatment for the initial metastasis improved post-metastatic survival rates, with tumor size and number being important variables for clinical decision-making. Patients with a smaller single metastasis had better post-metastasis survival rates compared to those with larger and multiple metastases. The 5-year post-metastatic survival rates were higher for patients with a smaller single metastasis.

CANCER MANAGEMENT AND RESEARCH (2021)

Article Oncology

Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi-institutional study

Eiji Kozawa, Yoshihiro Nishida, Akira Kawai, Keiko Hayakawa, Nokitaka Setsu, Hiroyuki Kawashima, Shintaro Iwata, Hiroyuki Tsuchiya, Satoshi Tsukushi, Satoshi Takenaka, Jungo Imanishi, Ichiro Baba, Akihito Nagano, Takeshi Morii, Toshiharu Shirai, Koki Shimizu, Hirotaka Kawano

Summary: This study evaluated the survival rates and prognostic factors in patients with dedifferentiated chondrosarcoma or grade 3 chondrosarcoma in Japan. The prognosis of dedifferentiated chondrosarcoma remains poor, and more effective and/or intensive chemotherapeutic regimens or agents should be considered or developed.

CANCER SCIENCE (2022)

Article Orthopedics

Hyaluronan in articular cartilage: Analysis of hip osteoarthritis and osteonecrosis of femoral head

Jiarui Zhang, Yoshihiro Nishida, Hiroshi Koike, Kan Ito, Lisheng Zhuo, Kazuki Nishida, Koji Kimata, Kunihiro Ikuta, Tomohisa Sakai, Hiroshi Urakawa, Taisuke Seki, Shiro Imagama

Summary: This study investigated the metabolism of HA in OA and ONFH, finding that KIAA1199 is overexpressed in OA cartilage but less expressed in ONFH cartilage. Additionally, the molecular weight of HA increased in OA cartilage but decreased in ONFH cartilage.

JOURNAL OF ORTHOPAEDIC RESEARCH (2023)

Article Oncology

Dedifferentiated liposarcoma in the extremity and trunk wall: A multi-institutional study of 132 cases by the Japanese Musculoskeletal Oncology Group (JMOG)

Takeshi Morii, Ukei Anazawa, Chiaki Sato, Shintaro Iwata, Makoto Nakagawa, Makoto Endo, Tomoki Nakamura, Kunihiro Ikuta, Yoshihiro Nishida, Robert Nakayama, Toru Udaka, Teruya Kawamoto, Munehisa Kito, Kenji Sato, Jungo Imanishi, Toru Akiyama, Hiroshi Kobayashi, Akihito Nagano, Hidetatsu Outani, Shunichi Toki, Toshihiko Nishisho, Keita Sasa, Yoshiyuki Suehara, Hirotaka Kawano, Takafumi Ueda, Hideo Morioka

Summary: Retrospective multicentric study analyzed the clinical characteristics, treatment outcomes, and risk factors for poor oncological outcomes in cases of dedifferentiated liposarcoma in the extremity or trunk wall. The study confirmed the typical clinical characteristics of dedifferentiated liposarcoma and identified independent risk factors for local recurrence, metastasis, and disease-specific mortality. Adequate evaluation and management of the dedifferentiated area, including grade, extension, and pathological margin, were crucial in the treatment of this entity.
Article Multidisciplinary Sciences

A clinical trial of a unidirectional porous tricalcium phosphate filling for defects after resection of benign bone lesions: a prospective multicenter study

Kunihiro Ikuta, Yoshihiro Nishida, Takehiro Ota, Satoshi Tsukushi, Eiji Kozawa, Hiroatsu Nakashima, Kenji Yamada, Satoshi Yamashita, Shiro Imagama

Summary: This study investigated the efficacy of Affinos on the healing process after filling bone defects. The results showed that radiographic evaluation and bone metabolic markers could predict the healing status at 12 months postoperatively in the defects followed by Affinos filling.

SCIENTIFIC REPORTS (2022)

Article Oncology

Clinical results of active surveillance for extra-abdominal desmoid-type fibromatosis

Tomohisa Sakai, Yoshihiro Nishida, Kan Ito, Kunihiro Ikuta, Hiroshi Urakawa, Hiroshi Koike, Shiro Imagama

Summary: Active surveillance (AS) has been shown to be an effective treatment modality for desmoid-type fibromatosis (DF). Neck location and CTNNB1 S45F mutation are significant factors associated with the transition to active treatment.

CANCER MEDICINE (2023)

Article Oncology

A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma

Mikiya Ishihara, Yoshihiro Nishida, Shigehisa Kitano, Akira Kawai, Daisuke Muraoka, Fumiyasu Momose, Naozumi Harada, Yoshihiro Miyahara, Naohiro Seo, Hiroyoshi Hattori, Kohichi Takada, Makoto Emori, Shigeki Kakunaga, Makoto Endo, Yoshihiro Matsumoto, Tetsuro Sasada, Eiichi Sato, Tomomi Yamada, Akihiko Matsumine, Yasuhiro Nagata, Takashi Watanabe, Shinichi Kageyama, Hiroshi Shiku

Summary: The efficacy of immune checkpoint inhibitors is limited in refractory solid tumors. TCR-T-cell therapy combined with pullulan nanogel: LPA vaccine has shown promising results in a mouse sarcoma model resistant to immune checkpoint inhibition. In a phase 1 trial, NY-ESO-1-specific TCR-T-cell therapy plus vaccination with the pullulan nanogel carrying an LPA containing the NY-ESO-1 epitope without lymphodepletion was found to be feasible and induced long-lasting therapeutic effects in refractory synovial sarcoma patients.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Otorhinolaryngology

Hand Grip Strength Assessment Based on Sarcopenia Diagnostic Criteria Predicts Swallowing Function

Takashi Okada, Hidetoshi Yamaguchi, Shinya Tanaka, Kyohei Koyama, Aika Hishida, Suzuna Konno, Masataka Nakamura, Hideshi Sugiura, Yoshihiro Nishida

Summary: The purpose of this study is to investigate whether grip strength can be used as an indicator of swallowing function. The results showed that grip strength assessment based on the criteria for sarcopenia can be a useful tool for estimating swallowing function.

DYSPHAGIA (2023)

Review Oncology

The current management of clear cell sarcoma

Kunihiro Ikuta, Yoshihiro Nishida, Shiro Imagama, Kazuhiro Tanaka, Toshifumi Ozaki

Summary: Clear cell sarcoma (CCS) is a rare melanocytic soft tissue sarcoma with high lymphatic metastasis and poor prognosis. The management of CCS remains challenging due to its rarity, unique biology, and limited understanding of its molecular pathogenesis. Surgical excision is the standard treatment, but the role of adjuvant therapy is uncertain. Targeted therapies and immunotherapy show promise but further research is needed.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Oncology

Selumetinib in Japanese pediatric patients with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas: An open-label, phase I study

Souichi Suenobu, Keita Terashima, Masaharu Akiyama, Tomoyo Oguri, Asako Watanabe, Masatoshi Sugeno, Mitsuo Higashimori, Karen So, Yoshihiro Nishida

Summary: This study evaluated the use of Selumetinib in Japanese children with neurofibromatosis. The results showed that the medication had a certain improvement in the patients' condition and the side effects were manageable.

NEURO-ONCOLOGY ADVANCES (2023)

Article Oncology

A randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610

Hiroshi Urakawa, Akihito Nagano, Ryunosuke Machida, Kazuhiro Tanaka, Tomoko Kataoka, Yuta Sekino, Yoshihiro Nishida, Mitsuru Takahashi, Toshiyuki Kunisada, Masanori Kawano, Yukihiro Yoshida, Tatsuya Takagi, Kenji Sato, Toru Hiruma, Hiroshi Hatano, Satoshi Tsukushi, Akio Sakamoto, Toshihiro Akisue, Koji Hiraoka, Toshifumi Ozaki

Summary: The superiority of preoperative denosumab was not observed in terms of relapse-free survival in patients with giant cell tumor of bone without possible post-operative large bone defect.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Surgical treatment for extremity rhabdomyosarcoma: longitudinal national questionnaire survey in Japan

Yoshihiro Nishida, Akira Kawai

Summary: A survey conducted in Japan on extremity rhabdomyosarcoma treatment revealed the necessity of continuing and devising more efficient enlightenment activities. The study found that a low percentage of facilities performed both excision and lymph node dissection, indicating the need for improved educational activities on appropriate treatment modalities for this type of cancer.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Clinical outcome in patients who underwent amputation due to extremity soft tissue sarcoma: Tokai Musculoskeletal Oncology Consortium study

Tomohito Hagi, Tomoki Nakamura, Akihito Nagano, Hiroshi Koike, Kenji Yamada, Hisaki Aiba, Nasa Fujihara, Junji Wasa, Kunihiro Asanuma, Eiji Kozawa, Daisuke Ishimura, Katsuhisa Kawanami, Yuya Izubuchi, Yoji Shido, Akihiro Sudo, Yoshihiro Nishida

Summary: This study investigated 55 patients with extremity soft tissue sarcoma who required amputation. The results showed that amputation is a useful treatment option for achieving local control, especially for patients with large tumors. Patients who underwent below the knee amputation had better survival prognosis and walking capabilities.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2022)

暂无数据